Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells
Article in Frontiers in Immunology (July 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (July 2024)
Article in International Immunopharmacology (June 2024)
Article in BMC Cancer (April 2024)